In 67 premenopausal women with uterine fibroids having laparoscopic myomectomy in Japan, 12 weeks of preoperative oral relugolix was non-inferior to leuprorelin for intraoperative blood loss (72.7 vs 84.4 mL; difference -11.7 mL).
RCTn = 67
Kobori et al. The effectiveness of relugolix compared with leuprorelin for preoperative therapy before laparoscopic myomectomy: a randomized controlled noninferiority study (MyLacR study)